Skip to main content
Zebrafish embryo_0
€1.8M EU funding awarded to CRACK IT Solutions provider, ZeClinics

ZeClinics has been awarded €1.87 million of EU funding to develop and commercialise "ZeCardio: High-throughput cardiotoxicity screening (HTS) with zebrafish embryo", an automated platform capable of analysing multiple parameters relating to the physiology of the heart and vascular system of zebrafish larvae. ZeCardio will be highly robotised and is capable of evaluating hundreds of new drugs daily, with high predictive confidence of their possible card

11 January 2017